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Cardiac papillary fibroelastomas are benign tumors characterized by 
myxoid degeneration and are a known risk factor for embolic events 
including TIA, stroke and myocardial infarction. Recent literature 
claims that they may in fact be more common than cardiac myxoma, 
but are usually discovered postmortem.1,2,3
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DISCUSSION
A Case of Recurrent Cerebrovascular Accident in the Setting of Cardiac  
Papillary Fibroelastoma
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CASE PRESENTATION
•  Cardiac papillomas are benign tumors that may be more 
common than previously thought.
•  This case demonstrates the importance of including cardiac 
papillary fibroelastoma in the differential diagnosis of 
cryptogenic and recurrent stroke, especially in patients 
on systemic anticoagulation with target-specific oral 
anticoagulants.
•  Although benign tumors, early detection of papillary 
fibroelastomas is crucial to prevent potential secondary 
complications. 
A 65 year old female with past history of paroxysmal atrial fibrillation 
on apixaban, hypertension, hyperlipidemia and TIA presented with 
encephalopathy and aphasia. Apixaban had been held for two doses 
for a dental procedure. Brain MRI revealed three diffuse bright foci 
in the right temporal and left parietal lobes. Her echocardiogram 
showed no embolic source. She restarted apixaban, but presented 
approximately two weeks later with dizziness. Repeat MRI revealed 
a new acute infarction in the right splenium of the corpus callosum. 
This was attributed to apixaban failure and she was switched to 
dabigatran. Transesophageal echocardiogram later revealed multiple 
echodense masses on mitral and aortic valve leaflets. Further work-
up ruled out vascular occlusive disease, atheromatous disease, 
infectious endocarditis, rheumatologic and hypercoagulable disorders. 
She underwent aortic and mitral valve exploration with excision 
of tumors from both valves. Surgical pathology revealed fibrotic 
tissue with focal areas of myxoid degeneration and micropapillary 
structures; consistent with papillary fibroelastoma.
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Figures A and B show T2 signal intensity located in left parietal lobe. Figure C shows T2 signal 
intensity located in right temporal lobe. Figure D shows acute infarction in the right splenium of the corpus 
callosum. Figures E and F show transesophageal echocardiographic view of echodense small masses on 
mitral valve leaflet.
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